Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.